Copyright Reports & Markets. All rights reserved.

Global Travelers Vaccination Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Travelers Vaccination Consumption Value by Type: 2020 Versus 2024 Versus 2031
    • 1.3.2 Meningococcal Vaccine
    • 1.3.3 Japanese Encephalitis Vaccine
    • 1.3.4 Yellow Fever Vaccine
    • 1.3.5 Hepatitis Vaccine
    • 1.3.6 Cholera Vaccine
    • 1.3.7 Other
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Travelers Vaccination Consumption Value by Application: 2020 Versus 2024 Versus 2031
    • 1.4.2 Tourists
    • 1.4.3 Students
    • 1.4.4 Workers
    • 1.4.5 Others
  • 1.5 Global Travelers Vaccination Market Size & Forecast
    • 1.5.1 Global Travelers Vaccination Consumption Value (2020 & 2024 & 2031)
    • 1.5.2 Global Travelers Vaccination Sales Quantity (2020-2031)
    • 1.5.3 Global Travelers Vaccination Average Price (2020-2031)

2 Manufacturers Profiles

  • 2.1 GSK
    • 2.1.1 GSK Details
    • 2.1.2 GSK Major Business
    • 2.1.3 GSK Travelers Vaccination Product and Services
    • 2.1.4 GSK Travelers Vaccination Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.1.5 GSK Recent Developments/Updates
  • 2.2 Sanofi Pasteur
    • 2.2.1 Sanofi Pasteur Details
    • 2.2.2 Sanofi Pasteur Major Business
    • 2.2.3 Sanofi Pasteur Travelers Vaccination Product and Services
    • 2.2.4 Sanofi Pasteur Travelers Vaccination Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.2.5 Sanofi Pasteur Recent Developments/Updates
  • 2.3 Merck
    • 2.3.1 Merck Details
    • 2.3.2 Merck Major Business
    • 2.3.3 Merck Travelers Vaccination Product and Services
    • 2.3.4 Merck Travelers Vaccination Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.3.5 Merck Recent Developments/Updates
  • 2.4 Pfizer
    • 2.4.1 Pfizer Details
    • 2.4.2 Pfizer Major Business
    • 2.4.3 Pfizer Travelers Vaccination Product and Services
    • 2.4.4 Pfizer Travelers Vaccination Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.4.5 Pfizer Recent Developments/Updates
  • 2.5 CNBG
    • 2.5.1 CNBG Details
    • 2.5.2 CNBG Major Business
    • 2.5.3 CNBG Travelers Vaccination Product and Services
    • 2.5.4 CNBG Travelers Vaccination Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.5.5 CNBG Recent Developments/Updates
  • 2.6 Serum Institute of India
    • 2.6.1 Serum Institute of India Details
    • 2.6.2 Serum Institute of India Major Business
    • 2.6.3 Serum Institute of India Travelers Vaccination Product and Services
    • 2.6.4 Serum Institute of India Travelers Vaccination Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.6.5 Serum Institute of India Recent Developments/Updates
  • 2.7 Biokangtai
    • 2.7.1 Biokangtai Details
    • 2.7.2 Biokangtai Major Business
    • 2.7.3 Biokangtai Travelers Vaccination Product and Services
    • 2.7.4 Biokangtai Travelers Vaccination Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.7.5 Biokangtai Recent Developments/Updates
  • 2.8 PaxVax
    • 2.8.1 PaxVax Details
    • 2.8.2 PaxVax Major Business
    • 2.8.3 PaxVax Travelers Vaccination Product and Services
    • 2.8.4 PaxVax Travelers Vaccination Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.8.5 PaxVax Recent Developments/Updates
  • 2.9 Valneva
    • 2.9.1 Valneva Details
    • 2.9.2 Valneva Major Business
    • 2.9.3 Valneva Travelers Vaccination Product and Services
    • 2.9.4 Valneva Travelers Vaccination Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.9.5 Valneva Recent Developments/Updates
  • 2.10 EuBiologics
    • 2.10.1 EuBiologics Details
    • 2.10.2 EuBiologics Major Business
    • 2.10.3 EuBiologics Travelers Vaccination Product and Services
    • 2.10.4 EuBiologics Travelers Vaccination Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.10.5 EuBiologics Recent Developments/Updates
  • 2.11 United Biotech
    • 2.11.1 United Biotech Details
    • 2.11.2 United Biotech Major Business
    • 2.11.3 United Biotech Travelers Vaccination Product and Services
    • 2.11.4 United Biotech Travelers Vaccination Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.11.5 United Biotech Recent Developments/Updates

3 Competitive Environment: Travelers Vaccination by Manufacturer

  • 3.1 Global Travelers Vaccination Sales Quantity by Manufacturer (2020-2025)
  • 3.2 Global Travelers Vaccination Revenue by Manufacturer (2020-2025)
  • 3.3 Global Travelers Vaccination Average Price by Manufacturer (2020-2025)
  • 3.4 Market Share Analysis (2024)
    • 3.4.1 Producer Shipments of Travelers Vaccination by Manufacturer Revenue ($MM) and Market Share (%): 2024
    • 3.4.2 Top 3 Travelers Vaccination Manufacturer Market Share in 2024
    • 3.4.3 Top 6 Travelers Vaccination Manufacturer Market Share in 2024
  • 3.5 Travelers Vaccination Market: Overall Company Footprint Analysis
    • 3.5.1 Travelers Vaccination Market: Region Footprint
    • 3.5.2 Travelers Vaccination Market: Company Product Type Footprint
    • 3.5.3 Travelers Vaccination Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Travelers Vaccination Market Size by Region
    • 4.1.1 Global Travelers Vaccination Sales Quantity by Region (2020-2031)
    • 4.1.2 Global Travelers Vaccination Consumption Value by Region (2020-2031)
    • 4.1.3 Global Travelers Vaccination Average Price by Region (2020-2031)
  • 4.2 North America Travelers Vaccination Consumption Value (2020-2031)
  • 4.3 Europe Travelers Vaccination Consumption Value (2020-2031)
  • 4.4 Asia-Pacific Travelers Vaccination Consumption Value (2020-2031)
  • 4.5 South America Travelers Vaccination Consumption Value (2020-2031)
  • 4.6 Middle East & Africa Travelers Vaccination Consumption Value (2020-2031)

5 Market Segment by Type

  • 5.1 Global Travelers Vaccination Sales Quantity by Type (2020-2031)
  • 5.2 Global Travelers Vaccination Consumption Value by Type (2020-2031)
  • 5.3 Global Travelers Vaccination Average Price by Type (2020-2031)

6 Market Segment by Application

  • 6.1 Global Travelers Vaccination Sales Quantity by Application (2020-2031)
  • 6.2 Global Travelers Vaccination Consumption Value by Application (2020-2031)
  • 6.3 Global Travelers Vaccination Average Price by Application (2020-2031)

7 North America

  • 7.1 North America Travelers Vaccination Sales Quantity by Type (2020-2031)
  • 7.2 North America Travelers Vaccination Sales Quantity by Application (2020-2031)
  • 7.3 North America Travelers Vaccination Market Size by Country
    • 7.3.1 North America Travelers Vaccination Sales Quantity by Country (2020-2031)
    • 7.3.2 North America Travelers Vaccination Consumption Value by Country (2020-2031)
    • 7.3.3 United States Market Size and Forecast (2020-2031)
    • 7.3.4 Canada Market Size and Forecast (2020-2031)
    • 7.3.5 Mexico Market Size and Forecast (2020-2031)

8 Europe

  • 8.1 Europe Travelers Vaccination Sales Quantity by Type (2020-2031)
  • 8.2 Europe Travelers Vaccination Sales Quantity by Application (2020-2031)
  • 8.3 Europe Travelers Vaccination Market Size by Country
    • 8.3.1 Europe Travelers Vaccination Sales Quantity by Country (2020-2031)
    • 8.3.2 Europe Travelers Vaccination Consumption Value by Country (2020-2031)
    • 8.3.3 Germany Market Size and Forecast (2020-2031)
    • 8.3.4 France Market Size and Forecast (2020-2031)
    • 8.3.5 United Kingdom Market Size and Forecast (2020-2031)
    • 8.3.6 Russia Market Size and Forecast (2020-2031)
    • 8.3.7 Italy Market Size and Forecast (2020-2031)

9 Asia-Pacific

  • 9.1 Asia-Pacific Travelers Vaccination Sales Quantity by Type (2020-2031)
  • 9.2 Asia-Pacific Travelers Vaccination Sales Quantity by Application (2020-2031)
  • 9.3 Asia-Pacific Travelers Vaccination Market Size by Region
    • 9.3.1 Asia-Pacific Travelers Vaccination Sales Quantity by Region (2020-2031)
    • 9.3.2 Asia-Pacific Travelers Vaccination Consumption Value by Region (2020-2031)
    • 9.3.3 China Market Size and Forecast (2020-2031)
    • 9.3.4 Japan Market Size and Forecast (2020-2031)
    • 9.3.5 South Korea Market Size and Forecast (2020-2031)
    • 9.3.6 India Market Size and Forecast (2020-2031)
    • 9.3.7 Southeast Asia Market Size and Forecast (2020-2031)
    • 9.3.8 Australia Market Size and Forecast (2020-2031)

10 South America

  • 10.1 South America Travelers Vaccination Sales Quantity by Type (2020-2031)
  • 10.2 South America Travelers Vaccination Sales Quantity by Application (2020-2031)
  • 10.3 South America Travelers Vaccination Market Size by Country
    • 10.3.1 South America Travelers Vaccination Sales Quantity by Country (2020-2031)
    • 10.3.2 South America Travelers Vaccination Consumption Value by Country (2020-2031)
    • 10.3.3 Brazil Market Size and Forecast (2020-2031)
    • 10.3.4 Argentina Market Size and Forecast (2020-2031)

11 Middle East & Africa

  • 11.1 Middle East & Africa Travelers Vaccination Sales Quantity by Type (2020-2031)
  • 11.2 Middle East & Africa Travelers Vaccination Sales Quantity by Application (2020-2031)
  • 11.3 Middle East & Africa Travelers Vaccination Market Size by Country
    • 11.3.1 Middle East & Africa Travelers Vaccination Sales Quantity by Country (2020-2031)
    • 11.3.2 Middle East & Africa Travelers Vaccination Consumption Value by Country (2020-2031)
    • 11.3.3 Turkey Market Size and Forecast (2020-2031)
    • 11.3.4 Egypt Market Size and Forecast (2020-2031)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2020-2031)
    • 11.3.6 South Africa Market Size and Forecast (2020-2031)

12 Market Dynamics

  • 12.1 Travelers Vaccination Market Drivers
  • 12.2 Travelers Vaccination Market Restraints
  • 12.3 Travelers Vaccination Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Travelers Vaccination and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Travelers Vaccination
  • 13.3 Travelers Vaccination Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Travelers Vaccination Typical Distributors
  • 14.3 Travelers Vaccination Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Travelers Vaccination market size was valued at US$ 3998 million in 2024 and is forecast to a readjusted size of USD 6440 million by 2031 with a CAGR of 7.1% during review period.
    A vaccine is a biological preparation that improves immunity to a particular disease. A vaccine typically contains an agent that resembles a disease-causing microorganism, and is often made from weakened or killed forms of the microbe, its toxins or one of its surface proteins. The agent stimulates the body"s immune system to recognize the agent as foreign, destroy it, and "remember" it, so that the immune system can more easily recognize and destroy any of these microorganisms that it later encounters.
    Travelers are at increased risk for several infections, including familiar infections such as measles that are widely distributed but more common in developing countries. Travelers Vaccines can markedly decrease the risk for many of these infections and are an important part of pretravel preparation.
    In this report, the travelers vaccines mainly covers vaccine for hepatitis A, hepatitis B, rabies, typhoid fever, yellow fever, Japanese encephalitis, meningococcal meningitis, cholera, etc.
    The travelers vaccination market is driven by the growing trend of international travel and the increasing awareness of the importance of travel vaccinations. As more people travel across borders for leisure, business, or humanitarian reasons, the risk of exposure to infectious diseases in different regions becomes significant. Travelers vaccination provides essential protection against diseases prevalent in specific destinations, such as yellow fever, typhoid, and hepatitis A. The rise in travel-related health risks and the need for pre-travel health consultations contribute to market growth as travelers seek to safeguard their health during their journeys. Moreover, advancements in vaccine formulations and the availability of combination vaccines have improved convenience and compliance for travelers. However, the market also faces challenges, including ensuring timely and appropriate vaccination before travel, as some vaccines require multiple doses over time. Additionally, addressing vaccine accessibility in remote or underserved areas and overcoming vaccine hesitancy among travelers can pose obstacles for comprehensive travel health protection. To succeed, companies must focus on research and development to offer travel-specific vaccine packages, collaborate with travel agencies and healthcare providers to promote travel health education, and address the challenges to meet the increasing demand for effective and tailored protection for travelers.
    This report is a detailed and comprehensive analysis for global Travelers Vaccination market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Travelers Vaccination market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
    Global Travelers Vaccination market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
    Global Travelers Vaccination market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
    Global Travelers Vaccination market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2020-2025
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Travelers Vaccination
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Travelers Vaccination market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include GSK, Sanofi Pasteur, Merck, Pfizer, CNBG, Serum Institute of India, Biokangtai, PaxVax, Valneva, EuBiologics, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market Segmentation
    Travelers Vaccination market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Meningococcal Vaccine
    Japanese Encephalitis Vaccine
    Yellow Fever Vaccine
    Hepatitis Vaccine
    Cholera Vaccine
    Other
    Market segment by Application
    Tourists
    Students
    Workers
    Others
    Major players covered
    GSK
    Sanofi Pasteur
    Merck
    Pfizer
    CNBG
    Serum Institute of India
    Biokangtai
    PaxVax
    Valneva
    EuBiologics
    United Biotech
    Market segment by region, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe Travelers Vaccination product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of Travelers Vaccination, with price, sales quantity, revenue, and global market share of Travelers Vaccination from 2020 to 2025.
    Chapter 3, the Travelers Vaccination competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Travelers Vaccination breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
    Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Travelers Vaccination market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
    Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
    Chapter 13, the key raw materials and key suppliers, and industry chain of Travelers Vaccination.
    Chapter 14 and 15, to describe Travelers Vaccination sales channel, distributors, customers, research findings and conclusion.

    Buy now